Jul 20, 2012 | Recent Deals | Silicon Valley
O’Melveny & Myers LLP represented Palo Alto Investors and Sofinnova Ventures in their co-investment with New Enterprise Associates in the US$40 million Series A Convertible Preferred Stock financing of Alimera Sciences. The closing of the financing is subject to customary closing conditions.
The O’Melveny deal team was led by partners Paul Scrivano and Brian Covotta, counsel Jeff Cislini, and associate Noah Kornblith.
Related Posts:
- O’Melveny Represents Samsung Electronics in its Acquisition of NeuroLogica
- O’Melveny Represents Microsemi in US$230 Million Acquisition of Symmetricom
- O’Melveny Represents Celsion in Registered Direct Offering
- O’Melveny Represents Celsion Corporation in a US$15 Million Private Placement
- O’Melveny Represents NextOp Software in Sale to Atrenta
